Drug firm Lupin on Tuesday said it has received an approval from the US health regulator to market Darunavir Tablets, used to treat Human Immunodeficiency Virus (HIV) infection, in the American market. The Mumbai-based company said it is the exclusive first filer for 800 mg tablets and is eligible for 180-day exclusivity. Lupin will also potentially have shared 180-day exclusivity on the 600 mg tablets, it added. The company has received the approval from the US Food and Drug Administration (USFDA) for the medication in strengths of 600 mg and 800 mg, Lupin said. The drug firm's product is a generic equivalent of Janssen Products' Prezista Tablets. As per MAT June 2022 data, Darunavir tablets (600 mg and 800 mg) had estimated annual sales of USD 343 million in the US. Lupin shares were trading 2.17 per cent up at Rs 738.30 apiece on the BSE.
Medicines to treat diabetes, HIV, TB, contraceptives, hormonal medicines included in National List of Essential Medicines
Health Canada approved the request by Canadian Blood Services to end the policy that restricts homosexuals from donating blood for three months after engaging in gay sex
French researcher Luc Montagnier, who won a Nobel Prize in 2008 for discovering the HIV virus and more recently spread false claims about the coronavirus, has died at age 89, according to officials
Sustainability and development have been key goals for the group
The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad
The product will be manufactured at the company's facility in Nagpur
Company plans to produce its jab at eight sites, including Serum Institute
The Haryana government will bring patients of the state suffering from cancer, HIV and serious kidney ailments under the ambit of its social security pension scheme.
The woes of MBBS students on Covid duty, many families continue to struggle for food and jobs, and lessons in living from the ocean-news relevant to India's fight against Covid-19
Approximately once every minute and 40 seconds, a child or young person under the age of 20 was infected with HIV last year, the UN Children's Fund (UNICEF) said on Wednesday
In a major study, researchers have identified the important factors which could be contributing to the chronic inflammation in people living with HIV.
Individuals with influenza-like illness symptoms, patients admitted with severe acute respiratory infection are to be tested.
Revised guidelines on home isolation of very mildly symptomatic, pre-symptomatic and asymptomatic patients supersede the order issued earlier
A combination of antiviral drugs commonly used to treat HIV showed no beneficial effects in patients hospitalised with COVID-19 in a large-scale randomised trial, scientists in the UK have found.
Indians have long seen deadlier diseases. We need to take all precautions and get on with our lives
Drug regulators must work to compress timeline for trials
The study said 50 of the children examined are showing signs of "severe immunodeficiency" but did not specify if they have full-blown AIDS.
HIV infections in newborns pose a huge health burden in developing countries. One study estimated that 300 to 500 infants are infected every day in sub-Saharan Africa
Kids have been long neglected by pharma firms because their number is much less compared to adults suffering from HIV, and so there is little money to be made